K Okuda, Y Sato, K Iwakawa, K Sasaki, N Okabe… - Journal of controlled …, 2022 - Elsevier
The use of lipid nanoparticles (LNPs) for nucleic acid delivery is now becoming a promising
strategy with a number of clinical trials as vaccines or as novel therapies against a variety of …